Nat Rev Cancer. 2024 Dec 16. IF: 72.5Conventional chemotherapy: millions of cures, unresolved therapeutic index.www.nature.com/articles/s41568-024-00778-4 Nat Rev Cancer. 2024 Dec 16. IF: 72.5PDX models for functional precision oncology and discovery science.www.nature.com/articles/s41568-024-00779-3 Lancet Oncol. 2024 Dec 16. IF: 41.6The changing global landscape of national cancer control plans.www.thelancet.com/journals/lanonc/article/PIIS1470-2045(24)00405-4 Nat Biotechnol. 2024 Dec 16. IF: 33.1CRISPR-StAR enables high-resolution genetic screening in complex in vivo models.www.nature.com/articles/s41587-024-02512-9 Cancer Commun (Lond). 2024 Dec 15. IF: 20.1Neoadjuvant HER2 inhibition induces ESR1 DNA methylation alterations resulting in clinically relevant ER expression changes in breast cancers.www.onlinelibrary.wiley.com/doi/10.1002/cac2.12640 Adv Sci (Weinh). 2024 Dec 16. IF: 14.3Ultrasound-Activated Precise Sono-Immunotherapy for Breast Cancer with Reduced Pulmonary Fibrosis.www.onlinelibrary.wiley.com/doi/10.1002/advs.202407609 Adv Sci (Weinh). 2024 Dec 16. IF: 14.3Ca2+- and cGAMP-Contained Semiconducting Polymer Nanomessengers for Radiodynamic-Activated Calcium Overload and Immunotherapy.www.onlinelibrary.wiley.com/doi/10.1002/advs.202411739 Adv Sci (Weinh). 2024 Dec 10. IF: 14.3Dual Inhibition of CDK4/6 and CDK7 Suppresses Triple-Negative Breast Cancer Progression via Epigenetic Modulation of SREBP1-Regulated Cholesterol Metabolism.www.onlinelibrary.wiley.com/doi/10.1002/advs.202413103 Small. 2024 Dec 15. IF: 13.0Freeze-Thaw-Induced Patterning of Extracellular Vesicles with Artificial Intelligence for Breast Cancers Identifications.www.onlinelibrary.wiley.com/doi/10.1002/smll.202408871 JAMA Netw Open. 2024 Dec 16;7(12):e2450391. IF: 10.5Cannabidiol for Scan-Related Anxiety in Women With Advanced Breast Cancer: A Randomized Clinical Trial.www.jamanetwork.com/journals/jamanetworkopen/fullarticle/2828077 J Natl Cancer Inst. 2024 Dec 5. IF: 9.9Benchmarks of Success in Radiotherapy versus Systemic Therapy National Clinical Trials Network (NCTN) Randomized Controlled Trials Sponsored by the National Cancer Institute (NCI).www.academic.oup.com/jnci/article/7917338 J Natl Cancer Inst. 2024 Dec 5. IF: 9.9Race and Clinical Outcomes in Hormone Receptor-Positive, HER2-Negative, Node-Positive Breast Cancer in the Randomized RxPONDER Trial.www.academic.oup.com/jnci/article/7917339 J Natl Cancer Inst. 2024 Dec 4. IF: 9.9Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancer.www.academic.oup.com/jnci/article/7916564 J Natl Cancer Inst. 2024 Dec 4. IF: 9.9Differential long-term tamoxifen therapy benefit by menopausal status in breast cancer patients: secondary analysis of a controlled randomized clinical trial.www.academic.oup.com/jnci/article/7915220 Nano Lett. 2024 Dec 16. IF: 9.6Rotavirus-Inspired Nanointerface Engineered Biosensors for All-in-One Cancer Diagnosis.pubs.acs.org/doi/10.1021/acs.nanolett.4c05210 Nano Lett. 2024 Dec 16. IF: 9.6Coagulation-Targeted TGF-beta Signaling Pathway Inhibitor Nanomedicine for Inhibiting the Growth and Lung Metastasis of Breast Cancer.pubs.acs.org/doi/10.1021/acs.nanolett.4c05355
